Innovative medical technologies in the percutaneous treatment of tricuspid regurgitation in Poland

Tricuspid regurgitation (TR) usually develops secondarily to left-sided heart diseases, whereas primary lesions to the valve apparatus is less common. Untreated severe TR has a poor prognosis and surgical treatment, i.e., valve repair or replacement, is the only treatment option with class I recomme...

Descripción completa

Detalles Bibliográficos
Autores principales: Witkowski, Adam, Dudek, Dariusz, Bartuś, Stanisław, Wojakowski, Wojciech, Gackowski, Andrzej, Grygier, Marek, Kuśmierczyk, Mariusz, Jaguszewski, Miłosz J., Kowalik, Ewa, Bondaryk, Katarzyna, Niewada, Maciej, Przygodzki, Piotr, Jakubczyk, Michał
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170310/
https://www.ncbi.nlm.nih.gov/pubmed/34671966
http://dx.doi.org/10.5603/CJ.a2021.0130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170310/
https://www.ncbi.nlm.nih.gov/pubmed/34671966
http://dx.doi.org/10.5603/CJ.a2021.0130

Ejemplares similares